A study recently published in Clinical Cancer Research and conducted at the Memorial Sloan Kettering Cancer Center in New York City investigated molecular profiling and the results that could potentially help clinicians make decisions on treatment for the patient. Read more . . .
Treatment decisions could be assisted through molecular profiling, which would allow patients and oncologists to evaluate the biological features of the tumor.